NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









E-Leviate Pharma

E-Leviate Pharma

Private
AucklandHealthcare & Life Scienceshttps://www.e-leviate.com/

Last Round

Seed

Dec 18, 2025

Total Funding Raised

$500,000

Company Overview

E-Leviate Pharma is a therapeutic devices company that develops a novel drug-device for a range of common gynecological conditions.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

women's healthestriol-eluting pessarypelvic organ prolapsePOPdrug-device combinationdrug-eluting devicevaginal pessaryfemtechdrug deliveryhormone therapygenitourinary syndrome of menopauseGSMvaginal atrophymedtechclinical-stage company

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

E-Leviate Pharma Comps

Public and private peers based on sector, stage, and business model.

E-Leviate Pharma comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

E-Leviate Pharma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedDec 18, 2025

Key People

Founding team and executive leadership

Prathima Chowdary

Chief Executive Officer

Executive Team

E-Leviate Pharma Investors

Notable investors and investment history

E-Leviate Pharma investors
InvestorRounds
Icehouse VenturesSeed
SOUL CapitalSeed
Outset VenturesPre Seed, Seed
Nuance Connected CapitalSeed
Clare VenturesPre Seed, Seed

E-Leviate Pharma Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

E-Leviate Pharma Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about E-Leviate Pharma's valuation, stock price, and market status.

Firmographic Details

HeadquartersAuckland
Employee Range5
Year Founded2023
Last FundingDec 18, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.